Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern

Medicine (United States)

Volumn 95, Issue 23, 2016, Pages

  Wehmeyer, Malte H ^a   Zyriax, Birgit Christiane ^b   Jagemann, Bettina ^a   Roth, Ewgenia ^a   Windler, Eberhard ^b   Wiesch, Julian Schulze Zur ^a   Lohse, Ansgar W ^a   Kluwe, Johannes ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

Etiology; NAFLD; NASH; Risk; Therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBOHYDRATE; CARBOXYLIC ACID; DISACCHARIDE; FRUCTOSE; GLUCOSE; LONG CHAIN FATTY ACID; MEDIUM CHAIN FATTY ACID; MINERAL; MONOSACCHARIDE; MONOUNSATURATED FATTY ACID; POLYSACCHARIDE; POLYUNSATURATED FATTY ACID; PROTEIN; SATURATED FATTY ACID; SHORT CHAIN FATTY ACID; STARCH; WATER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CALORIC INTAKE; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIETARY FIBER; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; FLUID INTAKE; FOOD FREQUENCY QUESTIONNAIRE; GERMANY; GLUCOSE INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINERAL INTAKE; NONALCOHOLIC FATTY LIVER; NUTRIENT CONTENT; NUTRITIONAL COUNSELING; PRIORITY JOURNAL; PROTEIN INTAKE; TERTIARY HEALTH CARE; WEIGHT REDUCTION; ADVERSE EFFECTS; DIET; FEEDING BEHAVIOR; FOLLOW UP; INCIDENCE; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITIONAL STATUS; RETROSPECTIVE STUDY;

DIET; ENERGY INTAKE; FEEDING BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITIONAL STATUS; RETROSPECTIVE STUDIES;

EID: 84975523637     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003887     Document Type: Article

References (29)

1. Marchesini G, Marzocchi R, Agostini F, et al. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005;16:421-7.
2. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012;107:811-26.
3. Masarone M, Federico A, Abenavoli L, et al. Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials 2014;9:126-33.
4. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-85.
5. Marrero JA, Fontana RJ, Su GL, et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349-54.
6. Wong VW, Wong GL, Yeung JC, et al. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: a prospective cohort study. Hepatology 2016;63:754-63.
7. Vanni E, Marengo A, Mezzabotta L, et al. Systemic complications of nonalcoholic fatty liver disease: when the liver is not an innocent bystander. Semin Liver Dis 2015;35:236-49.
8. Cortzes-Pinto H, Jesus L, Barros H, et al. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr 2006;25:816-23.
9. Volynets V, Küper MA, Strahl S, et al. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 2012;57:1932-41.
10. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008;48:993.
11. Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010;51:1961-71.
12. Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121-9.
13. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 2015;149:367-8.
14. Abenavoli L, Milic N, Peta V, et al. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J Gastroenterol 2014;20:16831-40.
15. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64:1388-402.
16. Zyriax BC, Lau K, Klähn T, et al. Association between alcohol consumption and carotid intima-media thickness in a healthy population: data of the STRATEGY study (Stress, Atherosclerosis and ECG study). Eur J Clin Nutr 2010;64:1199-206.
17. Segal KR, Van Loan M, Fitzgerald PI, et al. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 1988;47:7-14.
18. Sun SS, Chumlea WC, Heymsfield SB, et al. Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys. Am J Clin Nutr 2003;77:331-40.
19. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
20. Wong VWS, Vergniol J, Wong GLH, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurements in nonalcoholic fatty liver disease. Hepatology 2010;51:454-62.
21. Johansson I, Hallmans G, Wikman A, et al. Validation and calibration of food-frequency questionnaire measurements in the Northern Swedish Health and Disease cohort. Public Health Nutr 2002;5:487-96.
22. U.S. Department of Health and Human Services, U.S. Department of Agriculture. Dietary guidelines for Americans 2015-2020, 8th ed. Available at: http://health.gov/dietaryguidelines/2015/guidelines/. Accessed April 22, 2016.
23. Lankarani KB, Alavian SM. Low carbohydrate rather than low fat is more important in dietary management of nonalcoholic steatohepatitis. Gastroenterology 2015;149:1987.
24. Pericleous M, Mandair D, Caplin ME. Diet and supplements and their impact on colorectal cancer. J Gastrointest Oncol 2013;4:409-23.
25. Lin XF, Shi KQ, You J, et al. Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study. Mol Biol Rep 2014;41:2989-7.
26. Haufe S, Engeli S, Kast P, et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011;53:1504.
27. Wong VW, Wong GL, Choi PC, et al. Disease progression of nonalcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010;59:969-74.
28. Pais R, Charlotte F, Fedchuk L, et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 2013;59:550-6.
29. Singh S, Allen AM, Wang Z, et al. Fibrosis progression on nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired biopsy studies. Clin Gastroenterol Hepatol 2015; 13:643-54.